A study of Felzartamab in Participants with Lupus Nephritis

I'm Interested!

An Open Label Phase 1b Study of Felzartamab in Lupus Nephritis

Sex: Any
Age: Adult (18 - 64)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase I
Conditions Being Studied: Lupus

Study Purpose

The goal of this clinical trial is to evaluate the safety and tolerability of felzartamab plus standard of care in participants with refractory Lupus Nephritis (LN).

Who Can Participate

Age; 18-75 years old

Principal Investigator
Andrew Lazar MD

Department/Division
Medicine (Nephrology)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions

UH IRB: STUDY20240098
StudyID: 2024-01415
ClinicalTrials.gov: NCT06064929

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422